4.3 Article

Immortalized Canine Dystrophic Myoblast Cell Lines for Development of Peptide-Conjugated Splice-Switching Oligonucleotides

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy

Annemieke Aartsma-Rus et al.

NUCLEIC ACID THERAPEUTICS (2020)

Review Biochemistry & Molecular Biology

Optimization of antisense-mediated exon skipping for Duchenne muscular dystrophy

Kasia Dzierlega et al.

GENE THERAPY (2020)

Article Biochemistry & Molecular Biology

Creation and characterization of an immortalized canine myoblast cell line: Myok9

Sara Mata Lopez et al.

MAMMALIAN GENOME (2020)

Review Pharmacology & Pharmacy

Viltolarsen: First Approval

Sohita Dhillon

DRUGS (2020)

Review Genetics & Heredity

Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update

Chengmei Sun et al.

GENES (2020)

Article Multidisciplinary Sciences

Characterization of a novel microRNA, miR-188, elevated in serum of muscular dystrophy dog model

Hiroyuki Shibasaki et al.

PLOS ONE (2019)

Review Health Care Sciences & Services

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches

Yuko Shimizu-Motohashi et al.

JOURNAL OF PERSONALIZED MEDICINE (2019)

Article Pharmacology & Pharmacy

Viltotarsen for the treatment of Duchenne muscular dystrophy

R. R. Roshmi et al.

DRUGS OF TODAY (2019)

Article Biology

Considering aspects of the 3Rs principles within experimental animal biology

Lynne U. Sneddon et al.

JOURNAL OF EXPERIMENTAL BIOLOGY (2017)

Article Biotechnology & Applied Microbiology

Quantitative Antisense Screening and Optimization for Exon 51 Skipping in Duchenne Muscular Dystrophy

Yusuke Echigoya et al.

MOLECULAR THERAPY (2017)

Article Multidisciplinary Sciences

Effects of systemic multiexon skipping with peptide-conjugated morpholinos in the heart of a dog model of Duchenne muscular dystrophy

Yusuke Echigoya et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Editorial Material Biochemistry & Molecular Biology

FDA Approves Eteplirsen for Duchenne Muscular Dystrophy: The Next Chapter in the Eteplirsen Saga

Annemieke Aartsma-Rus et al.

NUCLEIC ACID THERAPEUTICS (2017)

Review Health Care Sciences & Services

Immortalized Muscle Cell Model to Test the Exon Skipping Efficacy for Duchenne Muscular Dystrophy

Quynh Nguyen et al.

JOURNAL OF PERSONALIZED MEDICINE (2017)

Article Biochemical Research Methods

Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting

Ling Liu et al.

NATURE PROTOCOLS (2015)

Article Biochemistry & Molecular Biology

Newborn bloodspot screening for Duchenne Muscular Dystrophy: 21 years experience in Wales (UK)

Stuart J. Moat et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2013)

Article Clinical Neurology

Efficacy of Systemic Morpholino Exon-Skipping in Duchenne Dystrophy Dogs

Toshifumi Yokota et al.

ANNALS OF NEUROLOGY (2009)

Article Cell & Tissue Engineering

A population of myogenic stem cells that survives skeletal muscle aging

Charlotte A. Collins et al.

STEM CELLS (2007)

Article Multidisciplinary Sciences

Direct isolation of satellite cells for skeletal muscle regeneration

D Montarras et al.

SCIENCE (2005)

Article Veterinary Sciences

Canine X-linked muscular dystrophy in Japan (CXMDj)

Y Shimatsu et al.

EXPERIMENTAL ANIMALS (2003)